Viatris reported $0.62 in EPS Earnings Per Share for its fiscal quarter ending in June of 2025.


Fiscal Calendar Actual Consensus Previous Date
FY2025Q3 Sep/2025 0.62 0.75 Nov/10 2025
FY2025Q2 Jun/2025 0.62 0.55 0.69 Aug/07 2025
FY2025Q1 Mar/2025 0.50 0.53 0.67 May/08 2025
FY2024Q4 Dec/2024 0.54 0.58 -0.64 Feb/27 2025
FY2024Q3 Sep/2024 0.75 0.68 0.27 Nov/07 2024
FY2024Q2 Jun/2024 0.69 0.68 0.75 Aug/08 2024
FY2024Q1 Mar/2024 0.67 0.67 0.77 May/09 2024
FY2023Q4 Dec/2023 -0.64 0.65 0.67 Feb/28 2024
FY2023Q3 Sep/2023 0.27 0.74 0.87 Nov/07 2023
FY2023Q2 Jun/2023 0.75 0.71 0.88 Aug/07 2023
FY2023Q1 Mar/2023 0.77 0.69 0.93 May/08 2023
FY2022Q4 Dec/2022 0.67 0.74 0.8 Feb/27 2023


Eps Change Date
Adcock Ingram Holdings ZAR 2.59 0.17 Dec/2024
Celltrion KRW 810.39 301.74 Jun/2025
Cspc Pharmaceutical CNY 0.13 0.08 Mar/2025
Dianthus Therapeutics USD -0.88 0.07 Jun/2025
Divis Laboratories Ltd 20.49 4.26 Jun/2025
Kangmei Pharma CNY 0 0 Jun/2025
Knight Therapeutics CAD 0 0.02 Sep/2024
Laboratorios Farma 0.42 1.39 Jun/2025
Malin Corporation 0 0 Dec/2024
Medical Developments International AUD 0 0.34 Dec/2024
Neuren Pharmaceuticals AUD 1.02 0.96 Dec/2024
Organigram Holdings CAD -0.05 0.16 Jun/2025
Pharma Mar EUR 1.32 1.55 Jun/2025
Qiagen NV USD 0.6 0.12 Jun/2025
Sartorius EUR 0.47 0.75 Jun/2025
Sino Biopharmaceutical CNY 0.19 0.16 Jun/2025
Tilray USD -1.78 0.54 Jun/2025
Viatris USD 0.62 0.12 Jun/2025
Zhangzhou Pientzehuang Pharmaceutical 0.73 0.93 Jun/2025